10-87931094-G-T
Variant summary
Our verdict is Pathogenic. Variant got 11 ACMG points: 11P and 0B. PM2PP3PP5_Very_Strong
The NM_000314.8(PTEN):c.253+5G>T variant causes a splice region, intron change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_000314.8 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 11 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PTEN | NM_000314.8 | c.253+5G>T | splice_region_variant, intron_variant | Intron 4 of 8 | ENST00000371953.8 | NP_000305.3 | ||
PTEN | NM_001304717.5 | c.772+5G>T | splice_region_variant, intron_variant | Intron 5 of 9 | NP_001291646.4 | |||
PTEN | NM_001304718.2 | c.-498+5G>T | splice_region_variant, intron_variant | Intron 3 of 8 | NP_001291647.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 29
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Cowden syndrome 1 Pathogenic:2
This variant is considered likely pathogenic. mRNA analysis has demonstrated abnormal mRNA splicing occurs [Myriad internal data, PMID: 28677221]. This variant has been reported in multiple individuals with clinical features of gene-specific disease [PMID: 24375884 ,28677221]. -
- -
not provided Pathogenic:2
Non-canonical splice site variant demonstrated to cause exon skipping and predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease (Chen et al., 2017); Observed in individuals with personal and/or family history consistent with PTEN hamartoma tumor syndrome (PHTS) referred for genetic testing at GeneDx and in published literature (Chen et al., 2017); Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 28677221, 24375884) -
The variant has been reported in individuals affected with Cowden syndrome and macrocephaly in the published literature (PMIDs: 24375884 (2014) and 28677221 (2017)). One cell-based study reports this variant results in skipping of exon 4 in the PTEN gene which is predicted to result in a frameshift (p.Ala72Thrfs*5), and is damaging to PTEN protein expression (PMID: 28677221 (2017)). Therefore, the variant is classified as pathogenic. -
PTEN hamartoma tumor syndrome Pathogenic:1
For these reasons, this variant has been classified as Pathogenic. Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Studies have shown that this variant results in skipping of exon 4 and introduces a premature termination codon (PMID: 28677221). The resulting mRNA is expected to undergo nonsense-mediated decay. ClinVar contains an entry for this variant (Variation ID: 427617). This variant has been observed in individuals with clinical features of PTEN hamartoma tumor syndrome (PHTS) (PMID: 24375884, 28677221; Invitae). It has also been observed to segregate with disease in related individuals. This variant is not present in population databases (gnomAD no frequency). This sequence change falls in intron 4 of the PTEN gene. It does not directly change the encoded amino acid sequence of the PTEN protein. RNA analysis indicates that this variant induces altered splicing and may result in an absent or disrupted protein product. -
Hereditary cancer-predisposing syndrome Pathogenic:1
The c.253+5G>T intronic pathogenic mutation results from a G to T substitution 5 nucleotides after coding exon 4 in the PTEN gene. This nucleotide position is highly conserved in available vertebrate species. This variant has been determined to be the result of a de novo mutation or germline mosaicism in one individual with PTEN hamartoma tumor syndrome (Vanderver A et al. Am J Med Genet A, 2014 Mar;164A:627-33). In silico splice site analysis predicts that this alteration will weaken the native splice donor site. RNA studies have demonstrated that this alteration results in out of frame exon 4 skipping in the set of samples tested (Chen HJ et al. Hum Mutat, 2017 Oct;38:1372-1377, Ambry internal data). Based on the supporting evidence, this variant is interpreted as a disease-causing mutation. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at